10 protocols were evaluated with respect to effectiveness of T cell depletion (pratocols 5 and 7 were most efficient). 0.1 ml of a rabbit anti (C57BL/6 or CBA) thymocytes (ALS) was injected intraperltoneally on days -4 and -2, 5 mg of cortisone acetate was injected in addition subcutaneously on day -6, or on day --6 and day -2. Mice did not respond to vaccinia virus with either protocol. ALS-treatment alone reduced anti-vaccinia responses about 2-5-fold, and cortisone acetate treatment alone had no significant effect.
were bled 10 d after the last boost. The result of the ALS plus cortisone treatment protocol was assessed by determining the numbers of spleen cells and the anti-vaccinia response of treated mice (Table I) MC57G (H-2), or D2 (H-2) target cells, as described previously (8) . Experimental details (duration of test, spontaneous release, etc.) are given in the Tables.
Results and Discussion
These experiments were designed to look for evidence in F1 ~ P 1 chimeras that antigen-presenting cells of F1 origin populate the thymus and function to select maturing Fa stem cells to express restriction specificity for P2. Longo and Schwartz (3) have presented evidence and argued that antigen-presenting cells of the thymus turn over more slowly than in spleens. Early on, therefore, stem cells transfused to irradiated recipients will be exposed to the original recipient type antigen-presenting cells in the chimera. When antigen-presenting cells have turned over in the thymus (at least partially) during the 6-12 wk after irradiation and reconstitution, mature T cell pools are replenished; therefore, chances for new T cells to differentiate and be selected for donor-type restriction specificities are relatively slim. One has to deplete chimeras of mature T cells that had been established 12-20 wk before to give stem cells a good chance to be selected by immigrated donor-type antigen-presenting cells in the thymus. Several protocols were used to deplete mature T cells in chimeras at ~3-4 mo after establishment of lymphohemopoietic chimerism. In Table II , experiments are summarized with chimeras treated with cortisone plus ALS (Table II , experiment 819, 8159) or with Cytoxan (150 mg kg) (Table II, experiment 810, 8159) or with three doses of 300 rad in 2-d intervals (Table II) . In all examples shown, there was no significant change of the restriction specificity pattern of treated chimeras vs. control chimeras; i.e., all experimental F1 ~ P1 animals generated virus-specific cytotoxic T cells restricted to P1 but not to P2. This finding was symmetrical in F1 P1 and F1 ~ P2 chimeras (experiment 8159). Chimeras were all H-2 typed serologically and some also by mixed lymphocyte culture; all were of F1 type.
When chimeras were irradiated a second time with 850 rad and reconstituted again with T cell-depleted F1 stem cells, their virus-specific effector T cells tested 12 wk after the second treatment expressed only recipient type restriction specificity (example, Table III ). These doubly irradiated chimeras possessed F1 lymphocytes by H-2 typing and by functional testing of effector T cells after anti-H-2 plus C treatment (8) .
Combined, these data (from experiments using four different protocols) show that F~ stem cells maturing in 3-5-too-old established F1 ~ P chimeras express recipient type restriction specificities predominantly. If there had been substantial numbers of antigen-presenting cells in the thymus derived from F~ stem cells that were able to select F1 stem cells during thymic maturation, all of the four protocols used should have allowed expression of both restriction specificities.
The results obtained cannot be explained simply by arguing that Fa stem cells had been eliminated by the various treatments, resulting in regeneration of host-type lymphocytes and restriction specificities. All of the chimeric lymphocytes were of F~ type, by serology and as determined by functional tests in several examples.
The experimental approach, where established chimeras were treated again with a protocol similar to that used for the induction of original chimerism, is particularly useful for discussing the role of radioresistant antigen-presenting cells vs. radioresistant thymic epithelial cells in selection of restriction specificities of cytotoxic T cells. Whatever artifacts are invoked to explain the failure of the usual F~ ~ P1 chimeras to express restriction specificity for P2, they apply also to the second irradiation and reconstitution protocol.
Our results differ from those published by Longo and Schartz (7) . Using the cortisone plus ALS protocol to reduce the mature T cell pool, they found that lymphocytes from F~ --o P1 chimeras expressed, with time, restriction specificity for P2. At least two possible (and testable) explanations for this discrepancy come to mind. First, because Longo and Schwartz tested T cell function and restriction in an antigen-specific proliferation assay, one may argue that induction and/or selection of restriction specificities of cytotoxic effector T cells has other requirements than that of nonlytic, differentiation-promoting T cells (helper, delayed type hypersensitivity, proliferative T cells). Differential expression of H-2 antigens might be compatible with this view, i.e., K and D are expressed more strongly on thymic epithelial cells of the cortex and suhcortex, whereas Ia antigens are found in the medullary region and there predominantly on macrophagelike cells, as shown by Rouse and Weissman (9) . Second, we used primary cytotoxic anti-viral T cell responses to assess restriction specificities, in contrast to the primed T ceils used for antigen-specific proliferative T cell assays. There is no doubt that restriction is a quantitative phenomenon. Because Chimezas were irradiated with g75 or 900 rad and reconstituted with 1-2 X 10": anti-0 + C-treated bone marrow cells. At the indicated thnc thereafter, they were treated as shown and tested after the interval shown. Test duration. 6 h; all chimeras were H-2 types; >90% of the spleen cells were of 1"~ origin.
,' .11 N Z in primary anti-vaccinia experiments activity on infected recipient-type targets is at least 10-30 times greater than the (in most cases unmeasurable) response on nonhost P2 targets, our results derive from the sensitive part of the titration curve. Titrations of proliferative T cell activities may be needed to assess whether there are no quantitative differences with respect to T cells restricted to P1 vs. P2.
Summary
The proposal was tested that (P1 × P2) Fa --o P1 irradiation bone marrow chimeras expressed predominantly Pl-restricted T cells because donor derived stem cells were exposed to recipient derived antigen-presenting cells in the thymus. Because P1 recipient-derived antigen-presenting cells are replaced only slowly after 6-8 wk by (P 1 × P2) donor-derived antigen-presenting cells in the thymus and because replenished pools of mature T cells may by then prevent substantial numbers of P2-restricted T cells to be generated, a large portion of thymus cells and mature T cells were eliminated using the following treatments of 12-20-wk-old (P1 × P2) F1 ~ P1 irradiation bone marrow chimeras: (a) cortisone plus antilymphocyte serum, (b) Cytoxan, (c) three doses of sublethal irradiation (300 rad) 2 d apart, and (d) lethal irradiation (850 rad) and reconstitution with T cell-depleted (P1 × P2) F1 stem cells. 12-20 wk after this second treatment, (P1 × P2) ~ P1 chimeras were infected with vaccinia-virus. Virus-specific cytotoxic T cell reactivity was expressed by chimeric T cells of (P1 × P2) F1 origin and was restricted predominantly to P1. Virus-specific cytotoxic T cells, therefore, do not seem to be selected to measurable extent by the immigrating donor-derived antigen-presenting cells in the thymus; their selection depends apparently from the recipient-derived radioresistant thymus cells.
